eCite Digital Repository

Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial

Citation

Sinn, N and Milte, CM and Street, S and Buckley, JD and Coates, AM and Petkov, J and Howe, PR, Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial, The British Journal of Nutrition: an international journal of nutritional science, 107 pp. 1682-1693. ISSN 0007-1145 (2012) [Refereed Article]


Preview
PDF
163Kb
  

Copyright Statement

Copyright 2011 The Authors

DOI: doi:10.1017/S0007114511004788

Abstract

Depressive symptoms may increase the risk of progressing from mild cognitive impairment (MCI) to dementia. Consumption of n-3 PUFA may alleviate both cognitive decline and depression. The aim of the present study was to investigate the benefits of supplementing a diet with n-3 PUFA, DHA and EPA, for depressive symptoms, quality of life (QOL) and cognition in elderly people with MCI. We conducted a 6-month double-blind, randomised controlled trial. A total of fifty people aged .65 years with MCI were allocated to receive a supplement rich in EPA (167 g EPA 016 g DHA/d; n 17), DHA (155 g DHA 040 g EPA/d; n 18) or the n-6 PUFA linoleic acid (LA; 22 g/d; n 15). Treatment allocation was by minimisation based on age, sex and depressive symptoms (Geriatric Depression Scale, GDS). Physiological and cognitive assessments, questionnaires and fatty acid composition of erythrocytes were obtained at baseline and 6 months (completers: n 40; EPA n 13, DHA n 16, LA n 11). Compared with the LA group, GDS scores improved in the EPA (P004) and DHA (P001) groups and verbal fluency (Initial Letter Fluency) in the DHA group (P004). Improved GDS scores were correlated with increased DHA plus EPA (r 039, P002). Improved self-reported physical health was associated with increased DHA. There were no treatment effects on other cognitive or QOL parameters. Increased intakes of DHA and EPA benefited mental health in older people with MCI. Increasing n-3 PUFA intakes may reduce depressive symptoms and the risk of progressing to dementia. This needs to be investigated in larger, depressed samples with MCI.

Item Details

Item Type:Refereed Article
Keywords:Mild cognitive impairment: Dementia: Depression: n-3 Fatty acids: EPA: DHA
Research Division:Medical and Health Sciences
Research Group:Nutrition and Dietetics
Research Field:Clinical and Sports Nutrition
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Blood Disorders
Author:Street, S (Dr Steven Street)
ID Code:113039
Year Published:2012
Web of Science® Times Cited:105
Deposited By:Health Sciences
Deposited On:2016-12-08
Last Modified:2017-03-22
Downloads:5 View Download Statistics

Repository Staff Only: item control page